Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India

MLA

Rajib De, et al. “Comparison of Efficacy and Safety of Thalidomide vs Hydroxyurea in Patients with Hb E-β Thalassemia - a Pilot Study from a Tertiary Care Centre of India.” Blood Cells, Molecules, and Diseases, vol. 88, May 2021, p. 102544. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f1db2dda6116c512c4dd539ee22d9035&authtype=sso&custid=ns315887.

APA

Rajib De, Manisha Jain, Pramit Ghosh, Prantar Chakrabarti, Prakas Kumar Mandal, Shuvra Neel Baul, & Tuphan Kanti Dolai. (2021). Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India. Blood Cells, Molecules, and Diseases, 88, 102544.

Chicago

Rajib De, Manisha Jain, Pramit Ghosh, Prantar Chakrabarti, Prakas Kumar Mandal, Shuvra Neel Baul, and Tuphan Kanti Dolai. 2021. “Comparison of Efficacy and Safety of Thalidomide vs Hydroxyurea in Patients with Hb E-β Thalassemia - a Pilot Study from a Tertiary Care Centre of India.” Blood Cells, Molecules, and Diseases 88 (May): 102544. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f1db2dda6116c512c4dd539ee22d9035&authtype=sso&custid=ns315887.